https://www.atomwise.com | United States | 2012 | $176.42M
Atomwise is a U.S.-based pharmaceutical company utilizing deep learning neural networks for small molecule drug discovery. The company’s AI platform, AtomNet, identifies and optimizes drug candidates across various therapeutic areas, including COVID-19. Atomwise has shown success in finding compounds with therapeutic potential and collaborates with pharmaceutical companies and research institutions. Co-founded by Abraham Heifets, the company focuses on AI-driven drug discovery.
